Michel van Agthoven started his career in 1998 as a scientific researcher in Health Technology Assessment at the Erasmus University and defended his PhD in 2004. In 2005 he started working for Janssen, where he held many functions in the Netherlands, Benelux and in international roles. He worked for Gilead Sciences for 2 years prior to returning to Janssen as management board member in 2016. As of 2022, Michel is Campus Lead for the Dutch Johnson & Johnson companies. He is also chairman of the AmCham Healthcare Committee, and holds memberships of the advisory board of the pharmaceutical association, the board of the Leiden BioScience Park and the economic board South-Holland.